Post-vaccine levels of antibodies to influenza hemagglutinin (HA) and neuraminidase (NA) decline slowly over 18 months in adults, and individuals vaccinated 2 years in a row have significantly lower immune responses, according to a study yesterday in the Journal of Infectious Diseases.
E coli and some Salmonella infections dropped, but Campylobacter and Vibrio cases increased.
An investigation into a norovirus outbreak near Portland, Ore., in July 2014 revealed that the source was a swimming beach at a park, outlining the risk and need for preventive steps, especially in settings where water isn't treated.
Blue Bell Creameries, which has been linked to 10 listeriosis cases in four states in an outbreak that spans several years, had evidence of Listeria in its Oklahoma plant as early as March 2013, a Food and Drug Administration (FDA) report today said, according to an Associated Press (AP) story.
Health officials in Ohio have confirmed botulism as the illness that sickened several people and killed one who attended the same church lunch in Lancaster, Ohio, on Apr 19, the Lancaster Eagle-Gazette reported on Apr 25.
The US Food and Drug Administration (FDA) at a conference yesterday presented a plan and schedule for implementing the Food Safety Modernization Act (FSMA), signed in 2011, according to Food Safety News.
Through a review of DNA data from listeriosis cases, federal health officials have identified two more patients who were affected by a Listeria monocytogenes outbreak linked to Blue Bell Creameries products, increasing the case count to 10.
Haiti and the Dominican Republic continue to report cholera cases in early 2015 well above levels seen during the same period last year, the Pan American Health Organization (PAHO) reported late last week.
A 9-month boy tested positive for Ebola after he died in Sierra Leone's Kailahun district, a former hot spot for the disease that had not seen a case over the past 4 months, Reuters reported today.
Two common antibiotics used for serious skin infections—clindamycin and trimethoprim sulfamethoxazole (TMP-SMX) —both had about an 80% success rate in curing uncomplicated methicillin-resistant Staphylococcus aureus (MRSA) skin infections, according to a study today in the New England Journal of Medicine (NEJM).